Michael J Fox Foundation Tour de Fox Series 2016

Global update

Author: Parkinson's Life editorsPublished: 2 June 2016

Prep: Cook: Serves:

The popular series of cycling events in the United States and Canada, organised by Team Fox, once again invites cyclists of all ages and abilities to grab their helmets, pump up their tyres and raise money for Parkinson’s disease research

From scenic rides taken at a leisurely pace to physically demanding mountainous routes the Tour de Fox Series offers something for everyone, of all cycling abilities.

Registration fee is US$50 per person and riders are also required to raise a minimum of US$200 by the day of the ride. You can register here.

The 2016 event schedule is as follows:

16 July: Great Lakes (Cleveland, Ohio, US)
20 August: Pacific Northwest (Vancouver, British Columbia, Canada)
27 August: Sonoma Wine Country (Santa Rosa, California, US)

Each event will start at 12pm local time and will host a finish-line festival with live music, food trucks and kid-friendly activities. Non-cyclists are invited to join finish-line festivities and all are welcome to participate and connect with the local Parkinson’s community.

Donations to the Tour de Fox will be accepted through the end of 2016.

Image credit: Tour de Fox facebook page

Read our interview with Sam Fox here

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

Discussing dyskinesia: Michael J Fox Foundation offers free live webinar

‘Dyskinesia: What to do about moving too much’

Steroid in shark livers could hold key to Parkinson’s treatment

New research suggests steroid may lead to next breakthrough

Global Parkinson’s study reveals sleep as biggest influence on wellbeing

First insights revealed from data gathered by smartphones

World War II weapon antidote could treat Parkinson’s

Researchers at Purdue University, US, are studying a World War II chemical weapon antidote that they believe could be used to treat Parkinson’s. It is believed the antidote, called dimercaprol, may be able to remove acrolein – a toxin that poisons neurons and can lead to the development of Parkinson’s disease. In addition to this, researchers believe dimercaprol can increase the survival rate of brain cells, improve mobility and reduce symptoms of pain. Riyi Shi, professor of neuroscience and biomedical engineering at Purdue University, said: “Our studies show that by removing the toxin (acrolein) from the brain, we are not just reducing the symptoms of Parkinson’s disease but also significantly reversing the damage of Parkinson’s disease. This could actually provide a new treatment for Parkinson’s patients.”

Repurposed cancer drug shows promise for Parkinson’s

Researchers at the Oxford Parkinson’s Disease Centre, UK, have repurposed an experimental cancer drug – called tasquinimod – as a potential treatment for Parkinson’s. The study – funded by Parkinson’s UK and published in science journal ‘Cell Stem Cell’ – has been tested on a total of 10 patients so far. As part of the research, the study grew brain cells from donated skin cell samples of people living with a rare genetic form of Parkinson’s – this process was then repeated on people with a common non-genetic form of the condition. Researchers found that tasquinimod can block HDAC4, a protein that causes Parkinson’s genes to become inactive. Professor Richard Wade-Martins, co-lead author of the study, said: “We think that switching off these genes in brain cells may play a vital role in the cell damage and death that occurs in Parkinson’s.”

Research survey assesses impact of holidays on Parkinson’s symptoms

The Radboud University Medical Center, Netherlands, is seeking participants for an online survey assessing the effects of a holiday on Parkinson’s. The study will assess whether a vacation can have physical and mental benefits for people living with the condition. It will also look at which specific factors, such as temperature and physical activity, can alleviate or increase symptoms. The Michael J Fox Foundation has approved the study’s protocol. Participants can sign up to complete the 20-minute survey online. The survey is open to anyone over 18 who has Parkinson’s and has been on vacation once or more between 1 June 2016 and 30 September 2018. Marjan Faber, the study’s daily supervisor, said: “If the study is able to identify decisive factors, those can act as a starting point for novel approaches in care for people with Parkinson’s disease.” To apply please visit research platform ParkinsonNEXT.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Michael J Fox Foundation Tour de Fox Series 2016

Global update

Author: Parkinson's Life editorsPublished: 2 June 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

Discussing dyskinesia: Michael J Fox Foundation offers free live webinar

Advances

Steroid in shark livers could hold key to Parkinson’s treatment

Advances

Global Parkinson’s study reveals sleep as biggest influence on wellbeing

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Michael J Fox Foundation Tour de Fox Series 2016

Global update

Author: Parkinson's Life editorsPublished: 2 June 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

Discussing dyskinesia: Michael J Fox Foundation offers free live webinar

Advances

Steroid in shark livers could hold key to Parkinson’s treatment

Advances

Global Parkinson’s study reveals sleep as biggest influence on wellbeing

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Sign in